Search images on Google      Product Monograph

Active Ingredients:

• rituximab, 10 MG/ML

DIN: 02495724

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: CONCENTRATE. SINGLE USE VIAL

Schedule: Prescription

Company: PFIZER CANADA ULC

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01F - (ATC, WHO)
• L01FA - (ATC, WHO)
• L01FA01 - RITUXIMAB (WHO)

 

External Links for Ruxience:

Search on Google

• Ruxience side effects
• Ruxience dosage
• rituximab side effects
• rituximab dosage